We provide real estate investors with advisory, acquisition, debt & structured finance, valuation, property management, leasing, and disposition services for the full spectrum of life sciences facilities. CBRE’s expertise spans many life sciences categories and property types and leads the industry in managing highly-regulated space.
Clients such as pharmaceutical, biotech, medical device and genomics, as well as contract research organizations (CROs) and contract manufacturing organizations (CMOs), rely on CBRE for their real estate services.
Related Insights
-
Explore the forces driving the life sciences recovery.
-
-
Recent Press
-
Signs emerged in the fourth quarter of a nascent recovery of U.S. life sciences real estate, including the first decline in vacancy in nearly four years, a sharp slowdown in construction and resilient demand for lab space, according to a new report from CBRE.
-
CBRE announced it has hired Mary Hines and Jennifer Vergara as Vice Chairs to its Life Sciences Practice in the San Francisco Bay Area. The duo specializes in tenant and landlord representation of life science across the Bay Area and are prominent figures in the commercial real estate industry locally and nationally.
-
Press Release
Life Sciences Sector: Construction Costs Up, Construction Activity Down
October 3, 2024
Construction costs for life sciences real estate have increased by 20% to 25% since before the pandemic and lab-construction activity has waned in the past two years, according to a new report from CBRE.
Search CBRE Life Sciences career opportunities
Leadership
Life Sciences Occupier Services
Real estate to create better outcomes for your life sciences business.
Core Values of our Solutions
We understand the critical nature of your portfolio and prioritize quality, compliance, health, and safety in everything we do.- Quality & Compliance: CBRE always keeps client's inspection-ready through client quality teams, a global network of life sciences quality experts, and standardized GxP compliant processes and technologies.
- Health & Safety: We know the complexities of life sciences research and manufacturing and rely on a strong safety program to assure our people operate safely, and our clients and visitors work in safe and healthy environments.
Related Insights
-
Explore the forces driving the life sciences recovery.
-
-
Leadership
Life Sciences Investor Services
Find your next life sciences investment
Real estate solutions down to a science
Comprehensive Investor Services
Life Sciences Construction Benchmarks & Trends 2024
Leadership
Featured Insights
-
Explore the forces driving the life sciences recovery.
-
-
-
Life sciences vacancy dips to 23% in Q4 2025 as construction hits a seven‑year low and absorption turns positive again.
-
CBRE’s Outlook analyzes Houston’s office, industrial, multifamily, retail and capital markets sectors for 2026.
-
-
-
CBRE Research provides insights on what’s in store for the Boston office, industrial, life science and retail markets for 2026.
-
Despite uncertainty, growth will continue for the U.S. commercial real estate market in 2026.
-
-
The Tri-Valley R&D Flex market closed Q4 2025 with an overall vacancy rate of 17.9%.
-
The Oakland R&D market closed Q4 2025 with an overall vacancy rate of 18.4%.
-
Article | Creating Resilience
Business Insights | Three Things to Know About Biomanufacturing Reshoring
October 14, 2025
Navigating this complex and competitive environment requires careful consideration of site selection, local incentives, infrastructure and financial strategies.
-
Report | Intelligent Investment
Boston 2025 U.S. Real Estate Market Outlook Midyear Review
August 6, 2025
CBRE's mid-year review analyzes Boston's office, industrial, life science and retail trends. Key takeaways for tenants and owners.
Insights from Full Spectrum Lab Services
Chromatography data systems (CDS) are essential tools in a laboratory setting, contributing to the generation of precise and dependable data across diverse scientific disciplines. These systems enhance productivity, uphold data integrity, and provide robust support for compliance with Good Manufacturing Practices.
In today’s data-rich landscape, data isn’t just a resource – it’s a superpower that can transform businesses, and the laboratory setting is no exception.
